Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuojin Pills for Functional Dyspepsia with Depression
NCT06481371Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jun 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of zuojin wan in functional dyspepsia (FD) and major depressive disorder (MDD) (2 arms), sponsored by Nanjing First Hospital. Primary endpoints: Depression symptom scale at 4 weeks, Functional Dyspepsia symptom scale at 4 weeks and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
zuojin wan
03
Conditions
functional dyspepsia (FD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06481371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06481371.